Browse studies

Find your next paid study

3,226 recruiting studies matching your filters

Phase II Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in PD-L1-Negative or Immunotherapy-refractory Esophagogastric Adenocarcinoma

The goal of this study is to learn about of the research study drug, telomelysin (OBP-301), in combination with pembrolizumab in advanced or metastatic gastric…

Esophageal AdenocarcinomaGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Weill Medical College of Cornell UniversityNCT06340711

Observational

Examining a Novel Treatment for Persistent Headache After Mild Traumatic Brain Injury

This study will test a new treatment, called Headache reprocessing, for persistent post-traumatic headache. The new treatment will be compared to a headache ed…

Post-Traumatic Headache

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT07229391

Observational

Pelvic Health Electrically Evoked Recording (PEER) 2 Study

To collect physiological signals at several timepoints during the therapy evaluation period.

Overactive BladderFecal IncontinenceUrinary Retention

Estimated

~$10 – $1,125

Actual pay is set by the research site.

MedtronicNeuroNCT05200923

Phase 2

A Phase II Randomized Trial of Intermittent Androgen Deprivation Therapy Alone or Combined With [177Lu]Lu-PSMA-617, With or Without Abiraterone and Prednisone, in Patients With Low-Volume Metastatic Hormone-Sensitive Prostate Cancer

This phase II trial tests leuprolide acetate alone versus in combination with 177Lu-PSMA-617, with or without abiraterone acetate and prednisone, for the treat…

Recurrent Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8Castration-Sensitive Prostate Cancer+9 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Molecular Residual Disease in Solid Tumors: A Prospective Study to Collect Clinical Data and Biospecimens to Support Discovery and Development of Cancer Biomarkers

The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II,…

Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Paradigm HealthNCT06605404

Observational

Safety and Feasibility Study of ATTN201 Centromedian Nucleus of the Thalamus Focused Ultrasound Stimulation for Enhanced Glymphatic Clearance in Amyloid Positive Patients With Mild Cognitive Impairment

The goal of this clinical trial is to learn if a wearable ultrasound device, called ATTN201, is safe and easy to use. The study is for adults ages 65 and older…

Alzheimer's Disease (AD)Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT07866768

Phase 1

Home-Based Outpatient Model for BCG Delivery: Reducing Undue Burden of NMIBC Treatment (Home-Run) Trial

This phase I/II trial tests the feasibility of home based BCG delivery to reduce undue burden on patients undergoing treatment for non-muscle invasive bladder …

Non-Muscle Invasive Bladder Carcinoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer CenterNCT07874347

Phase 1

A Phase 1/2, Open-label, Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, or NTRK1-3 Alterations (CARE)

Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic m…

Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Turning Point Therapeutics, Inc.NCT04094610

Phase 2

Phase 2 Study to Evaluate Reduced Dose Chemotherapy in Combination With Anti-PD-1 Therapy as First Line Treatment in Vulnerable or Older Adults (Vulnerable or Age ≥70) With Advanced PD-L1 TPS <50% Non-small Cell Lung Cancer

Evaluate frequency of adverse events that lead to chemotherapy discontinuation in vulnerable older adults with recurrent/metastatic PD-L1 TPS\<50% NSCLC patien…

Non-Small Cell Lung CancerNSCLCAdvanced Non-Small Cell Lung Cancer+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Virginia Commonwealth UniversityNCT06731413

Observational

The Effects of Transcutaneous Vagus Nerve Stimulation (tVNS) on Acute Pain Perception and Brain Activity in Healthy Adults

The goal of this clinical trial is to learn whether stimulating a nerve in the neck changes how much pain people feel. It also looks at whether this stimulatio…

Acute PainPain PerceptionHealthy Adult Participants

Estimated

~$10 – $1,125

Actual pay is set by the research site.

David A. PurgerNCT07827690

Observational

Overcoming the Barriers to Effective Transcranial Temporal Interference Stimulation in Humans

Transcranial temporal interference stimulation (TIS) is an emerging novel tool for non-invasive transcranial brain stimulation that holds the potential for foc…

Healthy Adult Participants

Estimated

~$10 – $750

Actual pay is set by the research site.

Northeastern UniversityNCT07593859

The REgistry of Very Early Estrogen and AnovuLation

The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevale…

Hypothalamic Amenorrhea, FunctionalHypothalamic AmenorrheaFunctional Hypogonadotropic Hypogonadism

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT06583408